CompuGroup Medical SE & Co. KGaA Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
CompuGroup Medical SE & Co. KGaA Stock Forecast and Price Target
The average price target for CompuGroup Medical SE & Co. KGaA's stock lately set by several renowned analysts is 42.25€, which would result in a potential upside of approximately 45.19% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of 65.00€ and a low estimate of 36.00€. Even if you're not interested in COP stock, you may be interested in its competitors.
45.19% Upside
CompuGroup Medical SE & Co. KGaA Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, CompuGroup Medical SE & Co. KGaA's Price has decreased from 57.55€ to 0.00€ – a 100.00% drop. In the next year, analysts predict that Fair Value will jump to 74.99€ – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ACN Stock Forecast | Accenture PLC | Outperform |
10
|
$313.54 | Buy/Sell | $374.25 | 25.82% |
| IBM Stock Forecast | International Business Machine... | Hold |
7
|
$184.10 | Buy/Sell | $175.67 | 3.20% |
| INFY Stock Forecast | Infosys | Outperform |
10
|
Rp1.43k | Buy/Sell | Rp1.53k | 13.05% |
| TRI Stock Forecast | Thomson Reuters | Hold |
7
|
C$209.09 | Buy/Sell | C$118.78 | -22.43% |
| IQV Stock Forecast | IQVIA Holdings | Outperform |
15
|
$240.84 | Buy/Sell | $267.27 | 14.18% |
CompuGroup Medical SE & Co. KGaA Revenue Forecast for 2023 - 2025 - 2030
In the last three years, CompuGroup Medical SE & Co. KGaA's Revenue has grown, moving from 869.21€M to 1.23€B – an increase of 41.25%. In the next year, analysts predict that Revenue will jump to 1.24€B – up 1.25% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 30.96%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTSH Stock Forecast | Cognizant Technology Solutions | Hold |
7
|
$67.52 | Buy/Sell | $76.23 | 18.48% |
| VEEV Stock Forecast | Veeva Systems | Outperform |
16
|
$200.52 | Buy/Sell | $216.48 | 22.18% |
| VRSK Stock Forecast | Verisk Analytics | Outperform |
18
|
$222.25 | Buy/Sell | $250.89 | 15.19% |
.jpg)
CompuGroup Medical SE & Co. KGaA Dividend per Share Forecast for 2023 - 2025 - 2030
CompuGroup Medical SE & Co. KGaA's Dividend per Share has decreased by 0.00% In the last two years, from 0.50€ to 0.50€. Analysts predict that CompuGroup Medical SE & Co. KGaA's Dividend per Share will increase in the upcoming year, reaching 0.64€. This would represent an increase of 28.00%. Over the next seven years, experts predict that CompuGroup Medical SE & Co. KGaA's Dividend per Share will grow at a rate of 39.71%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ICLR Stock Forecast | ICON Public | Buy |
16
|
$309.44 | Buy/Sell | $306.07 | 15.53% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
19.62€ | Buy/Sell | 19.42€ | -0.61% |
| CLVT Stock Forecast | Clarivate Plc | Outperform |
12
|
$7.11 | Buy/Sell | $8.44 | 12.52% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SECT B Stock Forecast | Sectra AB (publ) | Underperform |
14
|
kr217.80 | Buy/Sell | kr132.50 | -31.13% |
| CGM Stock Forecast | Cegedim | Outperform |
15
|
13.50€ | Buy/Sell | 20.82€ | 48.15% |
| AGFB Stock Forecast | Agfa-Gevaert NV | Outperform |
10
|
1.16€ | Buy/Sell | 3.00€ | 63.79% |
CompuGroup Medical SE & Co. KGaA EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for CompuGroup Medical SE & Co. KGaA has grown by 44.47%, going from 158.65€M to 229.20€M. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach 297.37€M – an increase of 29.74%. Over the next seven years, experts anticipate that EBITDA growth for CompuGroup Medical SE & Co. KGaA will be 55.19%.
CompuGroup Medical SE & Co. KGaA EBIT Forecast for 2023 - 2025 - 2030
In the last three years, CompuGroup Medical SE & Co. KGaA's EBIT has decreased by 5.65%, from 120.19€M to 113.40€M. In the next year, analysts predict that EBIT will reach 181.44€M – an increase of 60.00%. For the next seven years, the forecast is for EBIT to grow by 156.26%.
CompuGroup Medical SE & Co. KGaA EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, CompuGroup Medical SE & Co. KGaA's EPS has decreased from 1.88€ to 0.00€ – a 100.00% drop. In the next year, analysts predict that EPS will jump to 2.45€ – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
Site Navigation
.jpg)